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The psychosocial burden of psoriasis and barriers to biologic therapy in Hong Kong: patients’ 
perspectives
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introduction: Psoriatic skin lesions are often visible and have negative impact on patients’ quality of life (QoL). 
The introduction of biologic therapies has revolutionised the treatment of psoriasis. They are highly efficacious 
in clearing skin lesions and relieving joint symptoms. The use of biologics in psoriasis patients is associated 
with improved QoL and patient satisfaction. In Hong Kong, the psychosocial impacts of psoriasis on patients 
and their satisfaction towards various treatment modalities have not been well studied. Moreover, the ways 
local patients come to access the information on biologics and their concerns are unclear. 
Methods: We conducted a survey of 85 psoriasis patients from a patient self-help group to discern the disease 
impacts on QoL and patient attitudes towards biologics. The patients’ self-perceived disease severity and the 
disease impacts on physical, psychological, and social well-beings were assessed by a 10-point scale (1=minimal; 
10=maximal).
Results: The results show that 29% of patients (n=25) had mild (body surface area [BSA] <3%), 36% (n=31) had 
moderate (BSA 3-10%), and 34% (n=29) had severe (BSA >10%) psoriasis. The male-to-female ratio was 1.4:1. 
The mean age was 52.6±13.6 years. The median duration of disease was 8 years (3-13 years). The self-perceived 
disease severity was 7.68±2.70. Patients with moderate-to-severe psoriasis was associated with significantly 
higher self-perceived disease severity (P<0.01). The perceived disease impacts on six thematic issues were 
analysed: emotion (7.36±2.74); social life (6.92±2.81); general physical health (6.76±2.76); economy (5.67±3.20); 
job opportunity and work (5.61±3.30); and family life (4.76±2.64). Nearly half (48%) of patients was unsatisfied 
with current treatments. The main reasons were lack of treatment efficacy (58%), side-effects (29%), and high 
cost (20%). Only six (7%) patients had received biologic therapies; 46% of patients had never been informed 
or aware of biologic treatments in psoriasis. Most patients learned biologics through media (78%), medical 
personnel (20%), self-help groups (13%), and internet (11%).
Conclusion: Psoriasis has negative impacts on patients’ QoL, especially on psychosocial aspects. Majority 
of patients were unsatisfied with current treatments due to suboptimal disease control. Biologic therapy 
is underutilised in management of skin psoriasis and there is a lack of public awareness of such treatment 
modality. Medical professional has a potential pivot role in patient education of biologic therapy.
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introduction: Natural killer (NK)–cell leukaemia is common in Asia and South America populations. This is a 
fatal disease with the patients’ median survival time of around 2 months. Little is known about the molecular 
characteristics and pathogenetic mechanisms of the illness. The aim of this study was to identify novel 
pathogenic mutations in NK bone marrow by whole genome sequencing.
Methods: An adult NK leukaemia patient bone marrow sample sorted with CD56+ together with the skin 
biopsy were captured for whole genome sequencing. The somatic sequence changes identified will be further 
validated in other NK bone marrow samples by Sanger sequencing.
Results: The whole genome in both samples has an average coverage at 40X. A total of 42 single-nucleotide 
variations (SNVs) were identified in the NK bone marrow sample but absent in the skin biopsy. However, no 
recurrent SNVs were identified in three other NK bone marrow samples.
Conclusion: The identified SNVs need to be further validated with an increased number of NK bone marrow 
samples.
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